Core Insights - Align Technology reported revenue of $956.73 million for the quarter ended December 2023, reflecting a 6.1% increase year-over-year [1] - The earnings per share (EPS) was $2.42, up from $1.73 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $928.57 million by 3.03%, while the EPS surpassed the consensus estimate of $2.18 by 11.01% [1] Financial Performance Metrics - Clear Aligner Shipments totaled 593, slightly above the average estimate of 592 from two analysts [2] - Net revenues from Imaging Systems and CAD/CAM Services were $174.81 million, compared to the average estimate of $175.81 million, marking a year-over-year increase of 2.9% [2] - Total Clear Aligner net revenues reached $781.91 million, exceeding the estimated $753 million, representing a year-over-year growth of 6.9% [2] Stock Performance - Align Technology's shares have declined by 1.6% over the past month, while the Zacks S&P 500 composite increased by 3.3% [2] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [2]

Shares of Align Technology Inc. ALGN, +0.97% jumped 14.1% after hours on Wednesday after the company, best known for its Invisalign teeth-alignment system, forecast first-quarter and full-year sales that were above expectations. Align said it expected first-quarter sales of $960 million to $980 million, above the FactSet consensus forecast for $947 million. For the full year, the company expected sales to be “up mid-single digits” year over year, compared with FactSet expectations for around 4% growth. For ...

Core Insights - Align Technology, Inc. has been recognized in the Intellectual Property Owners Association's annual report as one of the top 300 organizations granted U.S. patents, ranking at position 270 with 158 patents granted in 2023, marking a 36% increase from 2022 [1][2] Company Innovations - The patents cover advancements in orthodontics and digital dentistry, including technologies for clear aligners, intraoral scanners, 3D printed orthodontic devices, restorative CAD/CAM software, and AI in treatment planning [2][3] - The iTero™ Lumina intraoral scanner features next-generation digital scanning technology with proprietary Multi-Direct Capture™ technology, offering a 3x wider field of capture, high accuracy, and a maximum capture distance of 25 mm, enhancing the scanning experience [2][3] - Align's first direct 3D printed orthodontic device, the Invisalign® Palatal Expander, provides a safe and effective alternative to traditional devices, eliminating the need for manual adjustments [3] Research and Development - Align has invested approximately $2 billion in R&D over nearly 27 years, focusing on innovations in digital dentistry through advancements in 3D computer modeling, material science, and biomechanics [3] - The recognition as a top patent producer reflects Align's commitment to developing next-generation devices and technologies that meet the needs of healthcare professionals [3] Market Position - Align Technology serves over 256,000 doctor customers and has treated approximately 17 million patients with the Invisalign system, indicating a significant market presence and opportunity [5] - The company aims to enhance digital orthodontic and restorative workflows, improving patient outcomes and practice efficiencies, while accessing a consumer market opportunity of 600 million worldwide [5]

Analysts on Wall Street project that Align Technology (ALGN) will announce quarterly earnings of $2.17 per share in its forthcoming report, representing an increase of 25.4% year over year. Revenues are projected to reach $928.43 million, increasing 3% from the same quarter last year.Over the last 30 days, there has been an upward revision of 1.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial for ...

Align Technology’s (ALGN) macroeconomic issues and currency headwinds continue to dent growth. The stock carries a Zacks Rank #4 (Sell).Align Technology is suffering from the ongoing industry-wide trend of staffing shortages and supply chain-related hazards. Deteriorating international trade, with global inflationary pressure leading to a tough situation related to raw material and labor costs, as well as freight charges and rising interest rates, all have put the dental treatment space (which is highly ele ...

Align Technology, Inc. (ALGN) is set to release fourth-quarter 2023 results on Jan 31 after the closing bell.The company posted adjusted earnings per share (EPS) of $2.14 in the last reported quarter, which missed the Zacks Consensus Estimate by 5.3%. Align Technology beat earnings estimates in three of the trailing four quarters and missed in one, the average negative surprise being 6.53%.Let’s look at how things have shaped up before this announcement.Factors at PlayClear Aligner BusinessDespite the diffi ...

Align Technologies (ALGN) is likely to grow in the coming quarters, backed by its impressive strategic alliances. Over the past couple of years, the company has successfully launched its first subscription-based clear aligner program, the Doctor Subscription Program (“DSP”), worldwide. A strong solvent balance sheet appears highly promising. However, the substantial dependence on the Invisalign system and currency fluctuations remain a concern for ALGN.In the past year, this Zacks Rank #3 (Hold) stock has i ...

Core Viewpoint - Align Technology, Inc. will report its fourth quarter and 2023 financial results on January 31, 2024, after market close, with a conference call scheduled for the same day to discuss these results [1][2]. Financial Reporting - The financial results will be released at 4:00 p.m. ET and will be accessible on the Investor Relations section of Align's website [1]. - A conference call to discuss the financial results will begin at 4:30 p.m. ET, available via audio webcast [2]. - Tentative earnings release dates for fiscal 2024 have been announced: Q1 on April 24, 2024; Q2 on July 24, 2024; and Q3 on October 23, 2024 [3]. Company Overview - Align Technology designs and manufactures the Invisalign® system, iTero™ intraoral scanners, and exocad™ CAD/CAM software, enhancing digital orthodontic and restorative workflows [4]. - The company serves over 252,000 doctor customers and targets a consumer market opportunity of 600 million worldwide [4]. - Align has treated over 16.4 million patients with the Invisalign system over the past 26 years, driving advancements in digital dentistry through the Align Digital Platform™ [4].

Key PointsA newly dovish FED has opened the floodgates for budget increases across the economy, and this sector is starting the trend by adding jobs.More than adding jobs, the sector has added investor interest in stocks like Pfizer and, most specifically, in Align Technology.Analysts and markets are all over this stock, and even the CEO has bought up to $2 million in stock ahead of the next rally.5 stocks we like better than PfizerBecause the past few months in the stock market have been a wild emotional r ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________ FORM 10-Q ____________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-32259 ____________________________ ALIGN TECHNOLOGY, INC. (Exact ...